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 Abstract  
In the laboratory setting, typical endocrine and targeted behavioral tests are limited in their 
ability to provide a direct assessment of stress in animals housed in undisturbed conditions. 
We hypothesized that an automated phenotyping system would allow the detection of subtle 
stress-related behavioral changes well beyond the time-frames examined using conventional 
methods. In the present study, we have utilized the TSE PhenoMaster system to continuously 
record basal behaviors and physiological parameters including activity, body weight, food 
intake, and oxygen consumption in undisturbed and stressed C57Bl/6J male mice (n = 
12/group), with a pharmacological intervention using the conventional anxiolytic, diazepam 
(5 mg kg
-1
 i.p.; n = 8/group). We observed significant 20-30% reductions in locomotor 
activity in the dark phase, with subtle reductions in light phase activity for up to 96 hours 
following a single 2 hour episode of restraint stress. A single administration of diazepam 
reduced plasma corticosterone concentrations by 30-35% during stress exposure when 
compared to mice treated with vehicle. This treatment did not result in significantly different 
locomotor activity compared to vehicle within the first 48 hours following restraint stress. 
However, diazepam treatment facilitated restoration of locomotor activity at 72 and 96 hours 
after restraint stress exposure in comparison to vehicle-treated mice. Hence, the use of an 
automated phenotyping system allows a real time assessment of basal behaviors and 
empirical metabolism following exposure to restraint stress and demonstrates major and 
subtle changes in activity persist for several days after stress exposure.  JU
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 Introduction 
Induction of psychological stress in the laboratory setting is a useful and highly studied 
technique known to cause a plethora of quantifiable changes from the behavioral to molecular 
level. It has been well documented that stress and the consequent responses are associated 
with many multifactorial diseases including psychiatric disorders, various inflammatory-
related, and neurodegenerative diseases (Glaser and Kiecolt-Glaser, 2005; Machado et al., 
2014; Wingenfeld and Wolf, 2011). To examine the effect of stress and its involvement in 
different disorders, researchers have employed multiple types of stressors including 
restraint/immobilization (Koo et al., 2010), cold/heat (Djordjevic et al., 2003) and 
lipopolysaccharide challenge (Perez-Nievas et al., 2010). Typically, assessment of stress 
utilizes both physiological and behavioral indicators, with one of the most commonly 
measured physiological responses being activation of the hypothalamic-pituitary-adrenal 
(HPA) axis, which ultimately triggers the release of glucocorticoids from the adrenal gland 
(Engelmann et al., 2004). Furthermore, multiple behavioral tests including forced swim, open 
field, elevated plus maze, sucrose preference, and step down avoidance are also used to 
assess the impact of stress in animals (Beery and Kaufer, 2015; Haller and Alicki, 2012; 
Nishimura et al., 1989). 
Although activation of the HPA axis can be monitored in blood through repeated sampling 
via catheters and dialysis, these methods are invasive and require surgical intervention. This 
limits their ability to provide a direct assessment of stress in live animals housed in 
undisturbed conditions. Several studies have attempted to assess the validity of non-invasive 
behavioral tests impacted by stress exposure by measuring parameters such as ambulation, 
rearing and grooming activity (Brodkin et al., 2014; Zimprich et al., 2014). In addition to 
these tests, high-throughput automated systems such as the TSE PhenoMaster have been 
developed to examine continuous undisturbed home-cage activity of rodents including 
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 locomotion and calorimetry (Clemmensen et al., 2015; Greenman et al., 2013). Given the 
wealth of knowledge on the effects of diazepam and stress on rodent behaviors (Belzung, 
2001; Zhao et al., 2012), the present study aims to test the sensitivity of the automated TSE 
PhenoMaster system and identify the time course of behavioral changes occurring after a 
single episode of restraint stress with or without a pharmacological intervention using 
diazepam. This may provide a platform to test stress-related compounds and their effects 
using continuously monitored behaviors in undisturbed conditions beyond time-domains that 
are practically achievable using typical experimental procedures. 
 
Methods 
Animals 
Wild-type C57Bl/6J male mice aged 10 - 11 weeks were obtained from the Animal Resources 
Centre in Canning Vale, Australia and group housed 4 per cage on arrival in the University of 
Queensland animal facility. Mice were housed in a 12-h light: dark phase (on at 06:00h and 
off at 18:00h) with room temperature maintained at 24 ± 2°C. One week before experimental 
manipulation, mice were relocated to the housing cages within the TSE PhenoMaster system, 
where mice were housed individually with free access to food and water with cage 
temperature tightly regulated at 24.5 ± 0.1°C. Mice were allowed 7 days to acclimate to the 
new housing conditions before the commencement of all experiments. All experimental 
procedures were approved by the University of Queensland Animal Ethics Committee and 
complied with the policies and regulations regarding animal experimentation. They were 
conducted in accordance with the Queensland Government Animal Research Act 2001, 
associated Animal Care and Protection Regulations (2002 and 2008), and the Australian 
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 Code of Practice for the Care and Use of Animals for Scientific Purposes, 8th Edition 
(National Health and Medical Research Council, 2013). 
Experimental Protocol 
Part A 
For the first part of the experiment, body weight, food intake, oxygen consumption, and 
activity were examined by monitoring baseline levels of these parameters for 24 hours in 
mice (n=12) housed within an automated TSE PhenoMaster system prior to the application of 
restraint stress (termed “Baseline”). All mice were subsequently subjected to a single 2 hour 
restraint stress from 10:00h to 12:00h using cylindrical metal restrainers (3 cm x 7 cm) 
equipped with nasal ventilation holes and a rear aperture clip. Immediately following stress 
cessation, mice were monitored for 96 hours within the automated TSE PhenoMaster system 
(termed “Post-Stress”; Fig. 1A). 
 
Part B 
For the second part of the experiment, the effects of diazepam on body weight, food intake, 
oxygen consumption, and activity were examined over time by monitoring a new cohort of 
naïve mice in TSE PhenoMaster system for 50 consecutive hours (beginning at 10:00h) 30 
minutes after mice (n=8/group) were injected intraperitoneally with diazepam (5mg kg
-1
; 
Hospira Australia Pty. Ltd.) or vehicle (53% propylene glycol, 31% ethanol and 16% water, 
pH=7.0) at a final volume of 1 mL kg
-1
 (Fig. 1B).  
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 Part C 
For the third part of the experiment, the effects of diazepam on restraint stress-induced 
changes in body weight, food intake, and activity were examined over time by monitoring 
another cohort of naïve mice in the TSE PhenoMaster system for 96 consecutive hours after 
mice (n=8/group) were injected intraperitoneally with diazepam (5 mg kg
-1
) or vehicle 30 
minutes prior to the onset of the 2 hour restraint stress at 10:00h to 12:00h (Fig. 1C).  
 
Part D 
In a separate experiment, the effects of diazepam on the restraint stress-induced responses in 
corticosterone and blood glucose concentrations were examined. Blood from diazepam- and 
vehicle-treated mice was collected prior to and during restraint stress exposure (Fig. 1D). 
Specifically, the distal 1 mm at the very tip of the tail was cut once only and blood samples 
were collected into chilled heparinized glass hematocrit tubes (HEMATO-CLAD® Mylar®, 
Drummond Scientific Company) and sealed with hematocrit clay (BD Seal-Ease
TM
). Mice 
were then intraperitoneally injected with diazepam and vehicle 30 min prior to application of 
a 2 hour restraint stress. Subsequent blood samples were collected at 1 and 2 hours, while 
mice were in the restrainers, by gently removing clotted blood from the tail. Each blood 
sample was approximately 25-30 µL, with the total volume collected much less than 10% of 
the calculated total blood volume. A 2.5 µL aliquot of whole blood was also used to measure 
blood glucose using a standard glucometer (Medisense® Optium glucometer, Abbot 
Laboratories, MA, USA) with an assay range of 1.1 – 27.8 mmol L-1 (20-500 mg dL-1). 
Whole blood samples were centrifuged at 1,250 x g for 15 minutes and supernatant plasma 
was collected and stored at -80°C for later analysis of corticosterone concentrations.  
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 Assessment of body weight, food intake, activity and metabolism 
The TSE PhenoMaster system comprises 2 environmental chambers each housing up to 8 
individual cages, allowing the monitoring of 16 mice in parallel with high resolution for 
activity, calorimetry, body weight, and food consumption. Oxygen consumption and carbon 
dioxide production in cages were measured through an open-circuit indirect calorimetry 
system and gas-sensing units where oxygen and carbon dioxide sensors were calibrated with 
calibration gas mixtures (CO2: 0.05 ± 0.0005%, O2: 20.8 ± 0.1% in N2; CO2: 0.95 ± 0.009%, 
O2: 20 ± 0.1% in N2) and the sample airflow adjusted to 0.25 L min
-1
. The cages also contain 
high precision sensor-associated weight and feeding baskets to accurately measure body 
weight and food intake (grams), with the feeders filled with standard chow and water bottles 
filled with distilled water. The apparatus is also equipped with a multi-dimensional infrared 
beam system for real time measurement of locomotor activity, defined as the total number of 
infrared beam breaks in the X and Y-axis (counts), where the beam break counts are 
subdivided into 1) fine movement or grooming resulting in the repeated break of the same 
light beam and 2) ambulatory movement which results in breaks of consecutive light beams. 
All measurements were taken hourly for the duration of assessment. 
 
Corticosterone assay 
Plasma corticosterone concentrations were determined as described previously (Chen et al., 
2014). Briefly, a 5 µL aliquot of plasma was extracted in 2 mL of glass-distilled 
dichloromethane with a mean extraction recovery of 85.2% and assay sensitivity of 10 pg 
mL
-1
. Extracts were dried under nitrogen gas and reconstituted in phosphate buffered saline 
containing 0.1% porcine gelatine (w/v). Unlabeled corticosterone standards and samples were 
incubated with anti- corticosterone antibody (Sapphire Bioscience Pty Ltd) and [1, 2, 6, 7-
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 3H]-corticosterone tracer. Unbound steroids were removed by addition of a dextran charcoal 
suspension followed by centrifugation at 1,000 x g for 10 min at 4°C. Radioactivity was 
quantified in a 100 µL aliquot of the resulting supernatant using a Liquid Scintillation 
Spectrometer (Tri-Carb 3100TR, Perkin Elmer) and samples were determined from the 
standard curve. Intra-assay and inter-assay coefficients of variation were 4.33% and 3.83% 
respectively.  
 
Statistical analysis 
All measures were performed using GraphPad Prism 6.0 (San Diego, CA, USA). For Part A, 
phenotype measures recorded for 24 hours prior to restraint stress were used for baseline data 
termed “Baseline”, and compared with “Post-Stress” recordings analyzed at 24 hour intervals 
for 96 hours following the release of mice from restraints. Data for “Baseline” and “Post-
Stress” at 24, 48, 72, and 96 hours for measures of body weight, food intake, oxygen 
consumption, locomotor and fine activity were analyzed using repeated measures one-way 
ANOVA with Greenhouse-Geisser correction for sphericity and a post hoc analysis using 
Dunnett’s test. For Part A and B, fine and locomotor activity were analyzed hourly for 4 
hours after restraint stress and injection to determine the initial response to either restraint 
stress or the injection procedure. All 24 hour cumulative counts for each measurement 
throughout the experiment, including Part B, were taken from 2 hours after the onset of 
treatment (i.e. at 12:00h) to account for the time animals were held in restraint. For Parts B, C 
and D, the statistical differences between vehicle and diazepam treatment for body weight, 
food intake, oxygen consumption, locomotor activity, fine activity, corticosterone and blood 
glucose concentrations were analyzed using repeated measures two-way ANOVA comparing 
the main effects of drug treatment and time following restraint stress. Where significant main 
JU
ST
 AC
CE
PT
ED
 effects were observed in the repeated measures two-way ANOVA, a post hoc analysis was 
performed using a Fisher’s least significant difference test for each time point. Normalized 
data are expressed as a percentage of the mean baseline vehicle-treated data. All data are 
presented as mean ± SEM and differences were considered significant when p ≤ 0.05. 
 
Results  
Physical restraint stress resulted in a sustained reduction in diurnal activity 
Using the automated TSE PhenoMaster system we monitored circadian locomotor and fine 
activity continuously for 96 consecutive hours following a single 2 hour episode of restraint 
stress (Fig. 2A & 2D). Repeated measures one-way ANOVA showed that locomotor activity 
was significantly reduced [F (2.31, 25.45) = 10.89, p = 0.0002]. Compared to baseline activity 
scores, there was an approximate 30% (p < 0.01) and 20% (p < 0.05) reduction in locomotor 
activity during the 24h and 48h periods immediately following restraint stress exposure 
respectively (Fig. 2B). Repeated measures one-way ANOVA showed that locomotor activity 
during the light and dark phase was significantly reduced[F (3.35, 36.79) = 5.94, p = 0.001; F (2.42, 
26.66) = 9.15, p = 0.0005 respectively]. Interestingly, the post hoc analysis revealed a decrease 
in locomotor activity in the light phase at 24h (p < 0.01), 48h (p < 0.05), 72h (p < 0.05), and 
96h (p < 0.05) after restraint stress exposure, whereas locomotor activity was decreased at 
24h (p < 0.01) after restraint stress exposure in the dark phase (Fig. 2C). A change in total 
locomotor activity was also reflected by a significant decrease in fine activity [F (2.16, 23.71) = 
6.03, p = 0.007].  Post hoc analysis showed an approximate 20% (p < 0.01) and 15% (p < 
0.01) decrease in fine activity at 24h and 48h following restraint (Fig. 2F). As with locomotor 
activity, fine activity during the light and dark phases was significantly decreased [F (2.88, 31.64) 
= 2.98, p = 0.048; F (2.55, 28.1) = 6.26, p = 0.003 respectively]. Post hoc analysis showed a 
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 reduction in fine activity at 48h (p < 0.05) after restraint stress during light phase and 
decreases in fine activity during the dark phase were evident at 24h (p < 0.05) following 
restraint (Fig. 2G). Interestingly, repeated measures one-way ANOVA showed that 1h 
following restraint stress  fine activity significantly increased by approximately 280% [F (2.51, 
27.64) = 34.33, p < 0.0001], while no other significant changes were observed at 2, 3, and 4 h 
after restraint (Fig. 2E).  
 
Oxygen consumption was also monitored (Fig. 2H), with a repeated measures one-way 
ANOVA showing that there was a significant reduction over the time-course of the 
experiment [F (2.21, 24.26) = 5.81, p = 0.007]. Post hoc analysis showed that cumulative rate of 
oxygen consumption was decreased in these mice at 24h following restraint stress likely 
reflecting the reduction in locomotor activity (p < 0.01; Fig. 2I). While mice consumed less 
oxygen during this time, energy expenditure relative to body weight did not change between 
baseline and 24 h post-stress measurements, indicating there was no measureable change in 
metabolic rate due to acute restraint stress (Fig. 2J). We also observed a transiently decreased 
body weight and food intake in mice during the 24 h period following restraint (data not 
shown).  
 
Diazepam facilitated recovery of restraint-induced reduction in activity and reduced 
corticosterone output 
Initially, the effect of diazepam alone on locomotor and fine activity was examined for 50 
consecutive hours following injection (Fig. 3A & 3D). The repeated measures two-way 
ANOVA demonstrated reduction in locomotor and fine activity following diazepam 
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 treatment [F (1, 14) = 18.28, p = 0.0008; F (1,14) = 17.34, p = 0.001] in the period immediately 
following injection [F (3, 42) = 28.83, p < 0.0001; F (3, 42) = 27.81, p < 0.0001]. There was also 
a significant interaction between diazepam treatment over time on locomotor and fine activity 
[F (3, 42) = 26.96, p < 0.0001 and F (3, 42) = 17.74, p < 0.0001 respectively]. Specifically, post 
hoc analysis showed that locomotor and fine activity significantly differed between treatment 
groups at 1h (p < 0.001) and 2h (p < 0.001) post injection (Fig. 3B and 3E). However, there 
were no significant differences in cumulative locomotor activity (Fig. 3C), cumulative fine 
activity (Fig. 3F), and oxygen consumption (Fig. 3G) for the 24h and 48h periods following 
vehicle or diazepam injection. The effects of diazepam on body weight and food intake were 
also examined post injection. While there was no difference in body weight for diazepam- 
and vehicle-treated mice, a transient increase in food intake after diazepam was observed 24h 
post-injection when compared to the vehicle group (data not shown).  
 
The effect of diazepam on locomotor and fine activity was also monitored for the 96h post-
restraint stress period (Fig. 4A & 4D). Repeated measures two-way ANOVA showed main 
effects of diazepam treatment [F (1, 14) =4.43, p = 0.05] and time [F (4, 56) = 29.83, p < 0.0001] 
on locomotor activity following restraint without significant interaction between treatment 
and time. Mice treated with diazepam showed increased locomotor activity at 72h (p < 0.05) 
and 96h (p < 0.05) post-stress when compared to the vehicle group (Fig. 4B). The repeated 
measures two-way ANOVA on locomotor activity data during the light and dark phase after 
restraint stress exposure revealed significant main effects of time [F (4, 56) = 5.86, p = 0.0005; 
F (4, 56) = 37.84, p < 0.0001] and diazepam treatment [F (1, 14) = 4.42, p = 0.05; F (1,14) = 3.86, p 
= 0.05] without any significant interaction between the two effects. There was a transient 
increase in locomotor activity at 72h (p < 0.01) post-stress during the light phase with a more 
prominent increase at 72h (p < 0.05) and 96h (p < 0.05) hours post-stress during the dark 
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 phase for diazepam-treated mice (Fig. 4C). Conversely, although fine activity was 
significantly reduced in the time following restraint [F (4, 56) = 11.99, p < 0.0001], diazepam 
treatment did not effectively attenuate these stress-induced reductions [F (1, 14) = 4.36, p = 
0.056] at 24, 48, 72, and 96h post-stress (Fig. 4E). Repeated measures two-way ANOVA 
showed similar main effects of time and diazepam treatment in the light and dark phases, 
indicating that diazepam did not attenuate the reduction in fine activity following restraint 
(Fig. 4F). 
 
Repeated measures two-way ANOVA revealed significant main effects of diazepam 
treatment [F (1, 42) = 22.31, p < 0.0001], time [F (2, 42) = 56.17, p < 0.0001], and the interaction 
between these main effects on plasma concentrations of corticosterone [F (2, 42) = 3.32, p = 
0.046]. A post-hoc analysis showed plasma corticosterone concentrations in mice 
administered diazepam was reduced by approximately 35% (p<0.001) and 30% (p<0.001) at 
1h and 2h of restraint stress exposure respectively compared to the vehicle group (Fig. 5A). 
The repeated measures two-way ANOVA also showed significant main effects of time [F (2, 
42) = 105.8, p < 0.0001] and diazepam treatment [F (1, 42) = 7.18, p = 0.01], while no 
significant interaction was observed between time and diazepam treatment on glucose 
concentrations. Diazepam reduced the acute elevation in blood glucose at 1h (p < 0.05), but 
this was not significantly different by 2h of stress when compared to vehicle-treated mice 
(Fig. 5B). The effects of diazepam on body weight and food intake were also examined 
throughout the 96h post-restraint stress period. While there was no difference in body weight 
for diazepam- and vehicle-treated mice, facilitation of food intake by diazepam was 
transiently observed 24 h post-stress when compared to the vehicle-treated mice (data not 
shown).   
JU
ST
 AC
CE
PT
ED
 Discussion 
In this study we have demonstrated the ability of an automated phenotyping system to 
monitor stress-related perturbations in behavior that occur following a single episode of 
restraint. Using the TSE PhenoMaster, we have identified sustained reductions in basal 
locomotor activity for up to 96 hours following exposure to a single restraint stress. These 
sustained changes were preferentially observed in the light phase of the light/dark cycle. We 
also observed delayed facilitation of stress-induced locomotor activity recovery following 
administration of a single dose of diazepam. Together with the transient changes observed in 
food and oxygen consumption, this demonstrates that the automated TSE PhenoMaster is 
capable of detecting subtle behavioral changes in mice beyond the measurable time-frames 
typically employed in normal experimental procedures.   
The present study has demonstrated decreased basal locomotor activity up to 96 hours 
following exposure to a single episode of restraint stress. When separated for light/dark phase, 
transient suppression occurred during the dark phase within the first 48 hours, while sustained 
decreases were observed in the light phase for up to 96 hours. This is consistent with previous 
studies indicating that locomotor activity decreases following exposure to severe stressors 
such as restraint (Brodkin et al., 2014; Chesworth et al., 2012). However, these studies were 
only limited to 15 – 30 minutes of post-stress recording and did not examine persistent 
changes in activity. Similar to Brodkin et al. (2014), we observed a significant increase in 
fine activity, which is suggested to represent grooming behavior, in the immediate hour 
following exposure to restraint (Robinson et al., 2013; Urbach et al., 2014). However, the 
cumulative fine activity over the 24 to 48 hours following restraint mirrors the changes 
observed in total locomotor activity, with the actual counts indicating that both fine and 
ambulatory activity are reduced. It should be noted that increased fine activity observed in the 
present study could also be representative of relatively immobile risk assessment behaviors. 
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 However, video and vibration analysis performed by Brodkin et al. (2014) indicated that 
many facets of risk assessment behavior including rearing, orienting (little to no body 
movement with small head movement/sniffing), and immobility were reduced while 
grooming behavior preferentially increased immediately after stress exposure.  
In order to test the sensitivity of the TSE PhenoMaster system to temporal changes in activity 
we administered a single dose of diazepam and observed an immediate sedative effect of 
diazepam on locomotor and fine activity. However, this effect was highly transient, differing 
significantly for only 2 hours from mice administered vehicle with no observable difference 
being recorded in cumulative counts collected over 48 hours. It has previously been shown 
that a single intraperitoneal injection of 1 mg kg
-1
 diazepam is rapidly absorbed into blood, 
yielding maximum serum concentrations in approximately 10 minutes after which decay into 
active metabolites yields an overall half-life of approximately 22 hours in mice. Therefore it 
is unlikely that diazepam is unavailable in this immediate 2 hour period following 
administration. When mice were monitored following diazepam administration and 
subsequent restraint stress, no immediate effects of the drug were observed in the stress-
induced reduction of locomotor and fine activity. Interestingly, the time of release from 
restraint approximately coincides with the duration of time elapsed to produce no significant 
differences in activity when diazepam was administered in the absence of restraint. Moreover, 
we observed a facilitated recovery from stress-induced reductions in locomotor activity 
occurring at 72 and 96 hours after stress exposure, an effect that was preferentially observed 
in the dark phase of the light cycle. It should be noted that the impact of a stressor such as 
restraint might initially override the observable effects of diazepam which subsequently 
become visible as the mouse recovers from stress exposure. Given the complex relationship 
that exists between benzodiazepines, stress, and behavior, further experiments will be 
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 required to determine the mechanism underlying this delayed facilitation of locomotor 
activity recovery. 
Underlying behavioral modification in models utilizing stress intervention is the overall 
increase in HPA axis activity. Using a single exposure to inescapable tail shock, Fleshner et 
al. (1995) observed an increase in circulating total corticosterone and decreased 
corticosteroid-binding globulin levels for up to 48 hours following shock exposure. Similarly, 
Tannenbaum et al. (1997) demonstrated that basal HPA axis activity, measured as circulating 
adrenocorticotropic hormone, free/total corticosterone, and corticosteroid binding globulin 
capacity were altered for up to 48 hours, and pituitary transcortin binding significantly 
decreased for up to 72 hours following a single 20 minute restraint stress. These changes 
were preferentially observed in the light phase and may relate to  the sustained suppression of 
basal locomotor activity observed during the light phase in the present study.  
Several studies have also demonstrated that single exposure to stress causes long-lasting 
changes in HPA axis activity (Armario et al., 2004; Dal-Zotto et al., 2000, 2003; Marti et al., 
2001; Valles et al., 2000). Using different rat models exposed to a single social defeat stressor, 
Meerlo et al. (1996; 1997) demonstrated changes in activity for several days similar to those 
observed in the present study following stress exposure. Calvo et al. (1998) also showed that 
corticosterone or dexamethasone administration were as effective as a 15 minute restraint 
stress at inducing anxiety-like behavior 24 hours later in the elevated plus maze. This effect 
was attenuated by the corticosterone synthesis inhibitor, metyrapone, indicating the 
importance of corticosterone in the generation of this behavior. 
While diazepam has potent anxiolytic activity, administration alone transiently increases 
basal corticosterone output. However, subsequent activation of the HPA axis is blunted, 
resulting in significantly decreased corticosterone responses to stress exposure (Kalman et al., 
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 1997; Mikkelsen et al., 2005). This is consistent with the results of the present study, where 
corticosterone concentrations were attenuated during restraint stress exposure following pre-
treatment with diazepam. However, it should be noted that the blunted corticosterone 
response to restraint might be the result of activated negative feedback on the HPA axis 
caused by diazepam-induced increases in basal corticosterone. Although Beracochea et al. 
(2011) have demonstrated diazepam dose-dependently attenuates the stress-induced increase 
in free corticosterone in the hippocampus, this has not been confirmed at the dose used in the 
present study. We also monitored stress-induced hyperglycemia following administration of 
diazepam or vehicle as this is a well-documented marker of increased catecholamine and 
glucocorticoid secretion (Halter et al., 1984; Vachon and Moreau, 2001). Interestingly, we 
observed a reduction in the peak glycemic response to restraint following diazepam 
administration. This is in contrast to Sugimoto et al. (1998) who showed diazepam 
administered at the same dose as the present study had no effect on stress-induced blood 
glucose concentrations. However, this may be due to their immediate application of stress in 
place of the 30-minute drug equilibration period following administration used in this present 
study. 
Following stress exposure there was a transient decrease in food intake and body weight in 
experimentally naïve animals during the first 24 hours. Both Martí et al. (1994) and Vallés et 
al. (2000) have previously observed this decrease in food intake 24 hours following restraint 
or immobilization stress in rats, with the latter study also demonstrating a decrease in body 
weight gain. However, unlike the transient changes observed in this present study, Vallés aet 
al. (2000) observed sustained and profound reductions in food intake for up to 8 days and 
substantial body weight differences lasting the 15 days duration of their experiment. While 
these differing results may indicate a relative resilience of mice over rats, Martí et al. (2001) 
also used corticosterone output to demonstrate the severity of immobilization stress in 
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 comparison to the restraint method used in this present work. In addition to the transient 
changes in food intake and body weight, the decrease in oxygen consumption observed in this 
present study did not translate to changes in metabolic rate when normalized for body weight 
and is likely the result of overall decreases in activity during this time period. In contrast, 
administration of diazepam transiently increased food intake during the first 24 hours after 
stress exposure. Benzodiazepines are known to induce increased food and water intake 
acutely after administration, an effect considered to be mediated by interaction with the 
mitochondrial diazepam binding inhibitor receptor responsible for neurosteroidogenesis and 
consequent GABA-A receptor modulation (Cooper and Estall, 1985; Reddy and Kulkarni, 
1998; Soderpalm and Berridge, 2000). However, as the increase in food intake observed in 
this study was only evident during the first 24 hours, it did not translate into lasting changes 
in body weight. 
 
Conclusions 
The automated behavioral monitoring system, TSE PhenoMaster allows the continuous 
monitoring of basal behavior and physiological parameters concurrently in multiple mice 
individually housed under undisturbed conditions for a period of weeks. Here we 
demonstrated disturbances in basal behaviors for up to 96 hours following a single episode of 
restraint. Moreover, mice administered a single prophylactic dose of a conventional 
anxiolytic pharmaceutical drug prior to restraint exposure facilitated recovery of stress-
induced locomotor reductions, while dampening restraint-evoked increases in plasma 
corticosterone and blood glucose concentrations. While these systems cannot replace targeted 
behavioral, endocrine, or biochemical testing, automated measures may offer further 
invaluable insights into the effects of stress on basal behavior and metabolism. Taken 
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 together, these results indicate that the use of an automated behavioral monitoring system is 
capable of identifying mice with irregular behavioral patterns indicative of anxiety and may 
be a useful tool for screening the effectiveness of pharmaceutical compounds outside of more 
targeted behavioral testing arenas. 
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Figure Legends 
Figure 1. Schematic timeline of experimental procedures. (A) In the first part of the 
experiment, naïve mice were habituated for a period of 7 days (green) to the home cages of 
the TSE PhenoMaster system after which 24h (12h light and 12h dark; 10:00h to 10:00h) of 
behavioral recording was collected (Baseline) prior to application of a 2 hour restraint stress 
(10:00h to 12:00h; red). Following stress application, mice were returned to the home cages 
and behavioral recording was continuously collected for 96h (12:00h to 12:00h; blue). (B) In 
the second part of the experiment, naïve mice were habituated for a period of 7 days (green) 
followed by a single intraperitoneal injection of diazepam (DZP; 5 mg kg
-1
) or vehicle (VEH) 
at 09:30h. After 30 minutes, recordings were collected for 2 hours for initial response to 
injection (10:00h to 12:00h) and a further 48 consecutive hours (12:00h to 12:00h; blue). (C) 
The third experiment involved a similar experimental procedure to Part A with the inclusion 
of the single intraperitoneal injection of DZP or VEH 30 min prior (09:30h; black) to 
application of a 2 hour restraint stress (10:00h to 12:00h; red). (D) In the last experiment, 
naïve mice were habituated for a period of 7 days (green). The baseline blood samples were 
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 collected from the tail, followed by a single intraperitoneal injection of DZP or VEH 30 min 
prior (09:30h; black) to application of a 2 hour restraint stress (10:00h to 12:00h; red). 
Subsequent blood samples were collected at 1h (11:00h) and 2h (12:00h) time points 
following restraint stress application.  
 
Figure 2. Single episode of two-hour restraint stress induces a prolonged reduction in 
locomotor and fine activity but no change in metabolic rate. Line graphs of continuous 
recording of (A) total locomotor activity, (D) fine activity, and (H) oxygen consumption 
during the dark (grey) and light (white) phase prior to and after acute restraint stress exposure 
(n = 12). The standard errors of mean (SEM) are indicated by dashed lines. The red vertical 
line depicts time of restraint. Mean ± SEM cumulative counts per 24 hours in (B) total 
locomotor activity and (F) fine activity were recorded for 96 hours following acute restraint 
stress (blue) when compared to the baseline recording (‘B’; green). These were separated into 
light and dark phase components for up to 96 hours following restraint stress (C & G). (E) 
Fine activity for 4 hours following acute restraint stress (blue) was compared to the fine 
activity prior to restraint stress application (green). (I) Mean ± SEM cumulative 24 hour 
measurements of oxygen consumption prior to and after acute restraint stress exposure were 
monitored for up to 96 hours and (J) shows linear regression of metabolic rates (energy 
expenditure relative to body weight) at baseline (green) and 24 hours (blue) after restraint 
stress. *p<0.05, **p<0.01, ***p<0.001 when compared to baseline recording; repeated 
measures one-way ANOVA with Dunnett’s test. 
 
Figure 3. Diazepam alone does not affect oxygen consumption, locomotor and fine 
activity. A line graph demonstrating continuous recording of (A) total locomotor activity and 
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 (D) fine activity during the dark (grey) and light (white) phase after vehicle (green line) and 
diazepam (blue line) injection (n = 8 per group). The standard errors of mean (SEM) are 
illustrated as dashed green and blue lines. (B & E) Locomoter and fine activity for 4 hours 
following acute restraint stress was compared between vehicle (green bar) and diazepam 
(blue bar). Mean ± SEM cumulative 24 hour measurements in (C) locomotor activity, (F) 
fine activity, and (G) oxygen consumption were compared in mice treated with vehicle (green 
bar) and diazepam (blue bar) at 24 and 48 hours post injection (n = 8 per group). ***p<0.001 
when comparing between vehicle and diazepam at each time point; repeated measures two-
way ANOVA with Fisher’s LSD test. 
Figure 4. Diazepam facilitates recovery of locomotor activity following a single episode 
of two-hour restraint stress. A line graph demonstrating continuous recording of (A) total 
locomotor activity and (D) fine activity during the dark (grey) and light (white) phase after 
acute restraint stress exposure in vehicle (green line) and diazepam (blue line) treated mice (n 
= 8 per group). The standard errors of mean (SEM) was illustrated as dashed green and blue 
lines. The red vertical line depicts time of restraint. Cumulative 24 hour counts in (B) 
locomotor and (E) fine activity from mice treated with vehicle (green bar) and diazepam 
(blue bar) were recorded for 96 hours following acute restraint stress. Cumulative 24 hour 
measurements for locomotor and fine activity were separated into light and dark phase for 96 
hours following acute restraint stress (C & F). *p<0.05, **p<0.01, ***p<0.001 when 
comparing between vehicle and diazepam at each time point; repeated measures two-way 
ANOVA with Fisher’s LSD test. 
 
Figure 5. Diazepam dampens restraint-evoked plasma corticosterone and blood glucose 
concentrations following a single episode of two-hour restraint stress. (A) Plasma 
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 corticosterone and (B) blood glucose concentrations were determined from serial blood 
samples collected at baseline, 1 and 2 hours of restraint-stress in vehicle (green line) and 
diazepam (blue line) treated mice. Data are represented as mean ± SEM from 8 mice per 
group; *p<0.05, ***p<0.001 when comparing between vehicle and diazepam at each time 
point; repeated measures two-way ANOVA with Fisher’s LSD test. 
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